The Virology Program Project continues its focus on the identification of interactions between viral and cellular proteins in herpesvirus infection and the effects of viral infection on cellular growth control. The program project includes basic studies of protein/DNA interactions on origins of replication, viral regulation of expression, viral effects on cell function, and the effects of tumor suppressor loss on viral tumorigenesis. Dr. Jack Griffith will continue his studies of herpes simplex virus (HSV) replication proteins, characterizing the replication complex on ori-S and the role of recombination proteins in initiation of replication. Dr. Shannon Kenney will pursue her studies of the Epstein Barr virus (EBV) ori-lyt and the role of BMRF1, the EBV polymerase processivity factor, and the Z and R transactivators and their effects on ori-lyt methylation and cellular repair mechanism. Dr. Joseph Pagano will continue his studies of Type III latency. He will analyze cell cycle effects and the role of the beta-catenin/TCF pathway in regulation of Type III latency. Dr. Eng Shang Huang has shown that HCMV gB binds to and activates the epidermal growth factor receptor. During this funding period, he will further characterize this interaction and, identify the domains of gB and EGFR that interact and develop a bacmid system to produce gB mutants in the context of the virus. Dr. Nancy Raab-Traub, Principal Investigator, will continue her studies of LMP1-induced transformation in transgenic mice and in rodent fibroblasts. She will further characterize the synergistic effects of loss of p16Ink4/p19ARF and LMP1 expression on lymphomagenesis and analyze transgenic mice that express both LMP1 and LMP2 in lymphocytes and epithelial cells. Overall, the Program Project will-continue to dissect the viral/cellular molecular interactions that occur during viral infection and determine how specific molecular events contribute to herpesvirus pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019014-31
Application #
7617149
Study Section
Subcommittee G - Education (NCI)
Program Officer
Daschner, Phillip J
Project Start
1997-05-01
Project End
2011-06-30
Budget Start
2009-04-01
Budget End
2011-06-30
Support Year
31
Fiscal Year
2009
Total Cost
$1,586,373
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Selitsky, Sara R; Marron, David; Mose, Lisle E et al. (2018) Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems 3:
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Lyons, Danielle E; Yu, Kuan-Ping; Vander Heiden, Jason A et al. (2018) Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. J Virol 92:
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
El-Mallawany, Nader Kim; Villiera, Jimmy; Kamiyango, William et al. (2018) Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer 13:33
Kobayashi, E; Aga, M; Kondo, S et al. (2018) C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. mSphere 3:
Hopcraft, Sharon E; Pattenden, Samantha G; James, Lindsey I et al. (2018) Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 14:e1007267

Showing the most recent 10 out of 324 publications